View Item 

Show simple item record

Malignancy risk for solitary and multiple nodules in Hürthle cell–predominant thyroid fine‐needle aspirations: A multi‐institutional study
dc.contributor.authorWong, Kristine S.
dc.contributor.authorJo, Vickie Y.
dc.contributor.authorLowe, Alarice C.
dc.contributor.authorFaquin, William C.
dc.contributor.authorRenshaw, Andrew A.
dc.contributor.authorShah, Akeesha A.
dc.contributor.authorRoh, Michael H.
dc.contributor.authorStelow, Edward B.
dc.contributor.authorKrane, Jeffrey F.
dc.date.accessioned2020-01-13T15:15:26Z
dc.date.availableWITHHELD_13_MONTHS
dc.date.available2020-01-13T15:15:26Z
dc.date.issued2020-01
dc.identifier.citationWong, Kristine S.; Jo, Vickie Y.; Lowe, Alarice C.; Faquin, William C.; Renshaw, Andrew A.; Shah, Akeesha A.; Roh, Michael H.; Stelow, Edward B.; Krane, Jeffrey F. (2020). "Malignancy risk for solitary and multiple nodules in Hürthle cell–predominant thyroid fine‐needle aspirations: A multi‐institutional study." Cancer Cytopathology (1): 68-75.
dc.identifier.issn1934-662X
dc.identifier.issn1934-6638
dc.identifier.urihttps://hdl.handle.net/2027.42/153015
dc.publisherSpringer
dc.publisherWiley Periodicals, Inc.
dc.subject.othermultinodularity
dc.subject.otherthyroid
dc.subject.otheratypia of undetermined significance (AUS)
dc.subject.otherfollicular lesion of undetermined significance (FLUS)
dc.subject.otherHürthle cell
dc.subject.othermalignancy risk
dc.subject.otherfine‐needle aspiration (FNA)
dc.titleMalignancy risk for solitary and multiple nodules in Hürthle cell–predominant thyroid fine‐needle aspirations: A multi‐institutional study
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/153015/1/cncy22213.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/153015/2/cncy22213_am.pdf
dc.identifier.doi10.1002/cncy.22213
dc.identifier.sourceCancer Cytopathology
dc.identifier.citedreferenceSclabas GM, Staerkel GA, Shapiro SE, et al. Fine‐needle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients. Am J Surg. 2003; 186: 702 ‐ 709; discussion 709‐710. doi: 10.1016/j.amjsurg.2003.08.015
dc.identifier.citedreferenceAlaedeen DI, Khiyami A, McHenry CR. Fine‐needle aspiration biopsy specimen with a predominance of Hürthle cells: a dilemma in the management of nodular thyroid disease. Surgery. 2005; 138: 650 ‐ 656; discussion 656‐657. doi: 10.1016/j.surg.2005.06.047
dc.identifier.citedreferenceElliott DD, Pitman MB, Bloom L, Faquin WC. Fine‐needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: acytomorphologic study of 139 cases with statistical analysis. Cancer. 2006; 108: 102 ‐ 109. doi: 10.1002/cncr.21716
dc.identifier.citedreferenceGonzalez JL, Wang HH, Ducatman BS. Fine‐needle aspiration of Hürthle cell lesions: a cytomorphologic approach to diagnosis. Am J Clin Pathol. 1993; 100: 231 ‐ 235. doi: 10.1093/ajcp/100.3.231
dc.identifier.citedreferenceKasper KA, Stewart J, Das K. Fine‐needle aspiration cytology of thyroid nodules with Hürthle cells: cytomorphologic predictors for neoplasms, improving diagnostic accuracy and overcoming pitfalls. Acta Cytol. 2014; 58: 145 ‐ 152. doi: 10.1159/000358264
dc.identifier.citedreferenceRenshaw AA. Hürthle cell carcinoma is a better gold standard than Hürthle cell neoplasm for fine‐needle aspiration of the thyroid: defining more consistent and specific cytologic criteria. Cancer. 2002; 96: 261 ‐ 266. doi: 10.1002/cncr.10797
dc.identifier.citedreferenceYang GC, Schreiner AM, Sun W. Can abundant colloid exclude oncocytic (Hürthle cell) carcinoma in thyroid fine needle aspiration? Cytohistological correlation of 127 oncocytic (Hürthle cell) lesions. Cytopathology. 2013; 24: 185 ‐ 193. doi: 10.1111/j.1365-2303.2012.00988.x
dc.identifier.citedreferenceRenshaw AA, Gould EW. Impact of specific patterns on the sensitivity for follicular and Hurthle cell carcinoma in thyroid fine‐needle aspiration. Cancer Cytopathol. 2016; 124: 729 ‐ 736. doi: 10.1002/cncy.21741
dc.identifier.citedreferenceWu HH, Clouse J, Ren R. Fine‐needle aspiration cytology of Hürthle cell carcinoma of the thyroid. Diagn Cytopathol. 2008; 36: 149 ‐ 154. doi: 10.1002/dc.20750
dc.identifier.citedreferenceAli SZ, Cibas ES. The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria, and Explanatory Notes. Springer; 2018.
dc.identifier.citedreferencePark HJ, Moon JH, Yom CK, et al. Thyroid “atypia of undetermined significance” with nuclear atypia has high rates of malignancy and BRAF mutation. Cancer Cytopathol. 2014; 122: 512 ‐ 520. doi: 10.1002/cncy.21411
dc.identifier.citedreferenceOnder S, Firat P, Ates D. The Bethesda System For Reporting Thyroid Cytopathology: an institutional experience of the outcome of indeterminate categories. Cytopathology. 2014; 25: 177 ‐ 184. doi: 10.1111/cyt.12091
dc.identifier.citedreferenceWu HH, Inman A, Cramer HM. Subclassification of “atypia of undetermined significance” in thyroid fine‐needle aspirates. Diagn Cytopathol. 2014; 42: 23 ‐ 29. doi: 10.1002/dc.23052
dc.identifier.citedreferenceKim SJ, Roh J, Baek JH, et al. Risk of malignancy according to sub‐classification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda System For Reporting Thyroid Cytopathology. Cytopathology. 2017; 28: 65 ‐ 73. doi: 10.1111/cyt.12352
dc.identifier.citedreferenceRenshaw AA. Should “atypical follicular cells” in thyroid fine‐needle aspirates be subclassified? Cancer Cytopathol. 2010; 118: 186 ‐ 189. doi: 10.1002/cncy.20091
dc.identifier.citedreferenceValderrabano P, Khazai L, Thompson ZJ, et al. Cancer risk stratification of indeterminate thyroid nodules: a cytological approach. Thyroid. 2017; 27: 1277 ‐ 1284. doi: 10.1089/thy.2017.0221
dc.identifier.citedreferenceSangalli G, Serio G, Zampatti C, Bellotti M, Lomuscio G. Fine needle aspiration cytology of the thyroid: a comparison of 5469 cytological and final histological diagnoses. Cytopathology. 2006; 17: 245 ‐ 250. doi: 10.1111/j.1365-2303.2006.00335.x
dc.identifier.citedreferenceKelman AS, Rathan A, Leibowitz J, Burstein DE, Haber RS. Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in indeterminate specimens. Thyroid. 2001; 11: 271 ‐ 277. doi: 10.1089/105072501750159714
dc.identifier.citedreferenceRoh MH, Jo VY, Stelow EB, et al. The predictive value of the fine‐needle aspiration diagnosis “Suspicious for a follicular neoplasm, Hürthle cell type” in patients with Hashimoto thyroiditis. Am J Clin Pathol. 2011; 135: 139 ‐ 145. doi: 10.1309/AJCP0RW2WMDUAKGK
dc.identifier.citedreferenceDeandrea M, Ragazzoni F, Motta M, et al. Diagnostic value of a cytomorphological subclassification of follicular patterned thyroid lesions: a study of 927 consecutive cases with histological correlation. Thyroid. 2010; 20: 1077 ‐ 1083. doi: 10.1089/thy.2010.0015
dc.identifier.citedreferenceRaparia K, Min SK, Mody DR, Anton R, Amrikachi M. Clinical outcomes for “suspicious” category in thyroid fine‐needle aspiration biopsy: patient’s sex and nodule size are possible predictors of malignancy. Arch Pathol Lab Med. 2009; 133: 787 ‐ 790. doi: 10.1043/1543-2165-133.5.787
dc.identifier.citedreferenceSippel RS, Elaraj DM, Khanafshar E, Kebebew E, Duh QY, Clark OH. Does the presence of additional thyroid nodules on ultrasound alter the risk of malignancy in patients with a follicular neoplasm of the thyroid? Surgery. 2007; 142: 851 ‐ 857. doi: 10.1016/j.surg.2007.08.011
dc.identifier.citedreferencePu RT, Yang J, Wasserman PG, Bhuiya T, Griffith KA, Michael CW. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine‐needle aspiration? Diagn Cytopathol. 2006; 34: 330 ‐ 334. doi: 10.1002/dc.20440
dc.identifier.citedreferenceSorrenti S, Trimboli P, Catania A, Ulisse S, De Antoni E, D’Armiento M. Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm. Thyroid. 2009; 19: 355 ‐ 360. doi: 10.1089/thy.2008.0338
dc.identifier.citedreferenceKauffmann PR, Dejax C, de Latour M, Dauplat J. The meaning and predictivity of Hürthle cells in fine needle aspiration cytology for thyroid nodular disease. Eur J Surg Oncol. 2004; 30: 786 ‐ 789. doi: 10.1016/j.ejso.2004.05.017
dc.identifier.citedreferenceGiorgadze T, Rossi ED, Fadda G, Gupta PK, LiVolsi VA, Baloch Z. Does the fine‐needle aspiration diagnosis of “Hürthle‐cell neoplasm/follicular neoplasm with oncocytic features” denote increased risk of malignancy? Diagn Cytopathol. 2004; 31: 307 ‐ 312. doi: 10.1002/dc.20132
dc.identifier.citedreferenceCastro MR, Espiritu RP, Bahn RS, et al. Predictors of malignancy in patients with cytologically suspicious thyroid nodules. Thyroid. 2011; 21: 1191 ‐ 1198. doi: 10.1089/thy.2011.0146
dc.identifier.citedreferenceTuranli S, Pirhan Y, Ozcelik CK, Cetin A. Predictors of malignancy in patients with a thyroid nodule that contains Hürthle cells. Otolaryngol Head Neck Surg. 2011; 144: 514 ‐ 517. doi: 10.1177/0194599810394052
dc.identifier.citedreferenceBrito JP, Yarur AJ, Prokop LJ, McIver B, Murad MH, Montori VM. Prevalence of thyroid cancer in multinodular goiter versus single nodule: a systematic review and meta‐analysis. Thyroid. 2013; 23: 449 ‐ 455. doi: 10.1089/thy.2012.0156
dc.identifier.citedreferenceCanberk S, Griffin AC, Goyal A, et al. Oncocytic follicular nodules of the thyroid with or without chronic lymphocytic thyroiditis: an institutional experience. Cytojournal. 2013; 10: 2. doi: 10.4103/1742-6413.106686
dc.identifier.citedreferenceMete O, Asa SL. Oncocytes, oxyphils, Hürthle, and Askanazy cells: morphological and molecular features of oncocytic thyroid nodules. Endocr Pathol. 2010; 21: 16 ‐ 24. doi: 10.1007/s12022-009-9102-2
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cncy22213.pdf
Size:
640.0KB
Format:
PDF
View/Open
Name:
cncy22213_am.pdf
Size:
231.7KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.